Physician profile
Ehab S Kasasbeh
NPI 1467645903
$17,988.14
in general payments reported to CMS, 2019-2025
51 companies · $1,648 in 2025
The $1,648 reported for 2025 was more than what 80% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,239 · 2020: $1,062 · 2021: $1,887 · 2022: $4,787 · 2023: $4,742 · 2024: $1,624 · 2025: $1,648.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,798 · Travel and Lodging: $1,215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,798.07 |
| Travel and Lodging | $1,214.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,522.21 | 2019-2025 | Optis, Diamondback Coronary, Assurity |
| Boston Scientific Corporation | $1,542.82 | 2019-2025 | Watchman Access System, Watchman Flx, Varithena Administration Pack |
| Cardiovascular Systems INC. | $1,380.27 | 2019-2023 | Diamondback Peripheral |
| Amgen INC. | $1,285.02 | 2019-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,134.45 | 2019-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $1,029.29 | 2019-2025 | Eliquis, Camzyos |
| Astrazeneca Pharmaceuticals LP | $881.19 | 2019-2025 | Farxiga, Brilinta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $870.83 | 2019-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $826.24 | 2019-2025 | |
| Pfizer INC. | $684.07 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $667.53 | 2019-2024 | Xarelto |
| Philips North America LLC | $559.14 | 2019-2025 | (9520) Igt Devices Undivided, Ecc Solutions, Coronary Undivided |
| Sanofi-Aventis U.S. LLC | $364.59 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $308.19 | 2021-2025 | |
| Shockwave Medical, INC | $281.72 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $273.57 | 2023-2024 | Indigo System |
| Merck Sharp & Dohme LLC | $231.57 | 2021-2025 | Verquvo |
| Baxter Healthcare | $200.19 | 2023-2024 | Hillrom - Carnation Ambulatory Monitor |
| Cardinal Health 200 LLC | $179.64 | 2019-2021 | |
| Vital Connect, INC | $165.99 | 2023-2025 | Vitalpatch Rtm |
| Regeneron Healthcare Solutions, INC. | $156.90 | 2019-2021 | |
| Irhythm Technologies, INC. | $135.33 | 2019-2024 | Zio Xt Patch, Zio Monitor |
| Esperion Therapeutics, INC. | $135.07 | 2021-2023 | Nexletol |
| Novo Nordisk INC | $97.65 | 2023 | Ozempic, Rybelsus, Wegovy |
| Bard Peripheral Vascular, INC. | $92.31 | 2020-2022 | |
| Becton, Dickinson and Company | $81.88 | 2021-2024 | Crosser Iq |
| Surmodics, INC. | $73.32 | 2023 | Pounce Venous Thrombectomy System, Pounce Thrombectomy System, Sublime Radial Access 018 Rx Pta Dilatation Catheter |
| Lundbeck LLC | $67.58 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $63.61 | 2025 | Opsumit, Uptravi |
| Tactile Systems Technology INC | $60.86 | 2024-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Abiomed | $59.43 | 2019-2020 | |
| Bardy Diagnostics, INC. | $52.00 | 2019-2020 | |
| Reflow Medical INC | $49.28 | 2025 | |
| Inspire Medical Systems, INC. | $47.02 | 2024 | Inspire |
| Triad Life Sciences INC. | $44.89 | 2022 | |
| Angiodynamics, INC. | $42.27 | 2021-2022 | |
| Inari Medical, INC. | $40.79 | 2021 | |
| Medtronic, INC. | $34.02 | 2021 | |
| Venclose INC. | $28.38 | 2020 | |
| Cagent Vascular INC | $25.01 | 2025 | Serrantor |
| Scpharmaceuticals INC. | $23.82 | 2023 | |
| Terumo Medical Corporation | $23.18 | 2019 | |
| Cordis US Corp. | $21.95 | 2023 | Brite Tip Radianz |
| Genzyme Corporation | $21.19 | 2024 | |
| Imperative Care, INC | $19.31 | 2025 | Symphony Catheter |
| Teleflex LLC | $18.83 | 2022 | |
| Vifor Pharma, INC. | $17.67 | 2021 | |
| Celonova Biosciences, INC. | $17.30 | 2019 | |
| Amarin Pharma, INC. | $16.93 | 2021 | |
| Cook Medical LLC | $16.04 | 2019 | |
| Impulse Dynamics (USA) INC. | $15.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ehab Kasasbeh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.